Nobuhiro Nishii

Medicine & Life Sciences

1. Brugada Syndrome 100%
2. Ventricular Fibrillation 52%
3. Implantable Defibrillators 38%
4. Heart Failure 25%
5. Electrocardiography 23%
6. Cardiac Resynchronization Therapy 23%
7. Lead 22%
8. Equipment and Supplies 20%
9. Ventricular Tachycardia 18%
10. Cardiac Arrhythmias 17%
11. Defibrillators 17%
12. Japan 14%
13. Tachycardia 13%
14. Registries 12%
15. Syncope 12%
16. 1,5-anhydro-1-(5-(4-ethoxybenzyl)-2-methoxy-4-methylphenyl)-1-thioglucitol 12%
17. Bundle-Branch Block 12%
18. Electric Impedance 11%
19. Atrial Fibrillation 10%
20. Sarcoidosis 10%
21. Primary Prevention 9%
22. Sodium Channel Blockers 9%
23. Heart Ventricles 9%
24. voglibose 8%
25. Hypertrophic Cardiomyopathy 7%
26. Hospitalization 7%
27. Ventricular Premature Complexes 7%
28. pilsicainide 7%
29. Catheter Ablation 7%
30. Brain Natriuretic Peptide 7%
31. Mutation 7%
32. Cardiac Resynchronization Therapy Devices 7%
33. Sudden Cardiac Death 6%
34. Dilated Cardiomyopathy 6%
35. Long QT Syndrome 6%
36. 4-hydroxy-2-nonenal 5%
37. Hemodynamics 5%
38. Shock 5%
39. Torsades de Pointes 5%
40. Fontan Procedure 5%
41. Therapeutics 5%
42. Databases 5%
43. Atrial Heart Septal Defects 5%
44. Coronary Artery Disease 5%
45. Stroke Volume 5%
46. Oxidative Stress 5%
47. alternan 5%
48. Pulmonary Arterial Hypertension 5%